TNFSF10 and prostate carcinoma: The combination of GlcN and TRAIL (GlcN/TRAIL) increased the activities of caspases 8, 9 and 3, further enhancing apoptosis over TRAIL alone in cancer cell lines sensitive to GlcN-induced deglycosylation such as DU145 prostate cancer cells.